Assuntos: ANTIRRETROVIRAIS, COVID-19, ENSAIO CLÍNICO, AGENTE TÓXICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARRUDA, E. A. G. et al. Clinical trial of efficacy and toxicity of disoproxil tenofovir fumarate and emtricitabine for mild to moderate SARS-CoV-2 infections. MedRXiv, p. 1-27, 2021Tradução . . Disponível em: https://doi.org/10.1101/2021.09.28.21264242. Acesso em: 10 out. 2025.APA
Arruda, E. A. G., Pires-Neto, R. J., Medeiros, M. S., Quirino-Filho, J., Clementino, M., Gondim, R. N. D. G., et al. (2021). Clinical trial of efficacy and toxicity of disoproxil tenofovir fumarate and emtricitabine for mild to moderate SARS-CoV-2 infections. MedRXiv, 1-27. doi:10.1101/2021.09.28.21264242NLM
Arruda EAG, Pires-Neto RJ, Medeiros MS, Quirino-Filho J, Clementino M, Gondim RNDG, Magalhães LMVC, Cavalcante KF, Viana VAF, Mello LP, Martins RB, Santos AA, Magalhães PJC, Havt A, Lopes NP, Arruda Neto E de, Lima AAM. Clinical trial of efficacy and toxicity of disoproxil tenofovir fumarate and emtricitabine for mild to moderate SARS-CoV-2 infections [Internet]. MedRXiv. 2021 ; 1-27.[citado 2025 out. 10 ] Available from: https://doi.org/10.1101/2021.09.28.21264242Vancouver
Arruda EAG, Pires-Neto RJ, Medeiros MS, Quirino-Filho J, Clementino M, Gondim RNDG, Magalhães LMVC, Cavalcante KF, Viana VAF, Mello LP, Martins RB, Santos AA, Magalhães PJC, Havt A, Lopes NP, Arruda Neto E de, Lima AAM. Clinical trial of efficacy and toxicity of disoproxil tenofovir fumarate and emtricitabine for mild to moderate SARS-CoV-2 infections [Internet]. MedRXiv. 2021 ; 1-27.[citado 2025 out. 10 ] Available from: https://doi.org/10.1101/2021.09.28.21264242
